Artificial Intelligence in Medicine
Volume 48, Issue 2 , Pages 129-137 , February 2010

Mixture classification model based on clinical markers for breast cancer prognosis

  • Tao Zeng
    • ,
  • Juan Liu

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +86 27 6277 3741; fax: +86 27 6877 8582.

Received 22 August 2008 ,Revised 9 July 2009 ,Accepted 20 July 2009.

References 

  1. van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome in breast cancer. Nature. 2002;415(6871):530–536
  2. Jarman IH, Etchells TA, Martín JD, Lisboa PJ. An integrated framework for risk profiling of breast cancer patients following surgery. Artificial Intelligence in Medicine. 2008;42(3):165–188
  3. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286(5439):531–537
  4. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, et al. Classification of human lung carcinomas by mrna expression profiling reveals distinct adenocarcinoma subclasses. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(24):13790–13795
  5. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell. 2002;1(2):203–209
  6. van de Vijver MJ, He YD, van’t Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene expression signature as a predictor of survival in breast cancer. The New England Journal of Medicine. 2002;347(25):1999–2009
  7. Spentzos D, Levine DA, Ramoni MF, Joseph M, Gu X, Boyd J, et al. Gene expression signature with independent prognostic significance in epithelial ovarian cancer. Journal of Clinical Oncology. 2004;22(23):4700–4710
  8. Spentzos D, Levine DA, Kolia S, Out H, Boyd J, Libermann TA, et al. Unique gene expression profile based on pathologic response in epithelial ovarian cancer. Journal of Clinical Oncology. 2005;23(31):7911–7918
  9. Li L. Survival prediction of diffuse large-b-cell lymphoma based on both clinical and gene expression information. Bioinformatics. 2006;22(4):466–471
  10. Dunkler D, Michiels S, Schemper M. Gene expression profiling: does it add predictive accuracy to clinical characteristics in cancer prognosis?. European Journal of Cancer. 2007;43(4):745–751
  11. Gevaert O, De Smet F, Timmerman D, Moreau Y, De Moor B. Predicting the prognosis of breast cancer by integrating clinical and micro-array data with Bayesian networks. Bioinformatics. 2006;22(14):e184–e190
  12. Edén P, Ritz C, Rose C, Fernö M, Peterson C. Good old clinical markers have similar power in breast cancer prognosis as micro-array gene expression profilers. European Journal of Cancer. 2004;40(12):1837–1841
  13. West D, Mangiameli P, Rampal R, West V. Ensemble strategies for a medical diagnostic decision support system: a breast cancer diagnosis application. European Journal of Operational Research. 2005;162(2):532–551
  14. Geurts P, Fillet M, de Seny D, Meuwis MA, Malaise M, Merville MP, et al. Proteomic mass spectra classification using decision tree based ensemble methods. Bioinformatics. 2005;21(14):3138–3145
  15. Peng Y. A novel ensemble machine learning for robust microarray data classification. Computers in Biology and Medicine. 2006;36(6):553–573
  16. Ge G, Wong GW. Classification of premalignant pancreatic cancer mass-spectrometry data using decision tree ensembles. BMC Bioinformatics. 2008;9:275
  17. Koziol JA, Feng AC, Jia Z, Wang Y, Goodison S, McClelland M, et al. The wisdom of the commons: ensemble tree classifiers for prostate cancer prognosis. Bioinformatics. 2009;25(1):54–60
  18. Ahr A, Holtrich U, Solbach C, Scharl A, Strebhardt K, Karn T, et al. Molecular classification of breast cancer patients by gene expression profiling. The Journal of Pathology. 2001;195(3):312–320
  19. Perreard L, Fan C, Quackenbush JF, Mullins M, Gauthier NP, Nelson E, et al. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Research. 2006;8(2):R23
  20. Hirose S, Shimizu K, Kanai S, Kuroda Y, Noguchi T. POODLE-L: a two-level SVM prediction system for reliably predicting long disordered regions. Bioinformatics. 2007;23(16):2046–2053
  21. Witten IH, Frank E. Data mining: practical machine learning tools and techniques with java implementations. San Francisco, CA: Morgan Kaufmann; 1999;
  22. Smith DD, Sætrom P, Lundberg OS, Rivas C, Glackin GEC, et al. Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation. BMC Bioinformatics. 2008;9:63
  23. Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, et al. Meta-analysis of gene-expression profiles in breast cancer: toward a unified understanding of breast cancer sub-typing and prognosis signatures. Breast Cancer Research. 2008;10:R65
  24. Bazan JG, Szczuka MS, Wroblewski J. A new version of rough set exploration system. In: TSCTC’02: proceedings of the third international conference on rough sets and current trends in computing. London, UK: Springer-Verlag; 2002;p. 397–404
  25. Chang CC, Lin CJ. LIBSVM: a library for support vector machines. URL http://www.csie.ntu.edu.tw/∼cjlin/libsvm [accessed: 29/06/2009]; 2001.
  26. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell. 2006;10(6):529–541
  27. Elfilali A, Lair S, Verbeke C, La Rosa P, Radvanyi F, Barillot E. ITTACA: a new database for integrated tumor transcriptome array and clinical data analysis. Nucleic Acids Research. 2006;34(Database issue):D613–D616
  28. Gruvberger S, Ringnér M, Chen Y, Panavally S, Saal LH, Borg A, et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Research. 2001;61(16):5979–5984
  29. Foulkes WD, Grainge MJ, Rakha EA, Green AR, Ellis IO. Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status. Breast Cancer Research and Treatment. 2009;117(1):199–204
  30. Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M. Prognostic value of histologic grade nuclear components of Scarff–Bloom–Richardson (SBR), an improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer. 1989;64(9):1914–1921
  31. Hemminki K, Ji J, Försti A, Sundquist J, Lenner P. Survival in breast cancer is familial. Breast Cancer Research and Treatment. 2008;110(1):177–182
  32. Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, Rennert HS, et al. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. The New England Journal of Medicine. 2007;357(2):115–123

PII: S0933-3657(09)00099-2

doi: 10.1016/j.artmed.2009.07.008

Artificial Intelligence in Medicine
Volume 48, Issue 2 , Pages 129-137 , February 2010

Article Tools

* Image Usage & Resolution